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Abstract
BACKGROUND: Following the announcement of the World Health Organization (WHO) on January 30, 2020, 
of coronavirus disease (COVID)-19 as a global and emergency state of international health emergency; posing 
a serious threat to the physical health and lives of individuals transmitted through respiratory droplets and close 
contact. The virus causes respiratory symptoms and damages to other organs, sometimes leading to death in case 
of exacerbation of symptoms. 
AIM: This study was conducted through reviewing various articles related to COVID-19 disease, with the purpose of 
reviewing the epidemiology, prevention and control strategies of COVID-19 coronavirus in Iran.
METHODS: In the present review study, the articles indexing in the Persian and Latin databases of SID, Magiran, 
PubMed, Scopus, Scholar, Web of Science, Embase, MedRxiv, and WHO were examined based on MESH keywords. 
Finally, 38 articles, 5 protocols and reports were reviewed.
RESULTS: According to the report of the WHO on July 22, 2020, 14,765,256 people worldwide have been infected 
and 612,054 people have died of this virus. Moreover, in Iran, according to the WHO report, 278,827 people were 
infected and 14,634 people died of the virus until July 22, 2020. Respiratory droplets are the main way of transmission 
and it can also be transmitted through close contact. According to research, 51% of patients with chronic disease 
show symptoms such as fever (83%), cough (82%), shortness of breath (31%), muscle pain (11%), fatigue (9%), 
headache (8%), sore throat (5%), had rhinorrhea (4%), chest pain (2%), diarrhea (2%), and nausea and vomiting 
(1%). There is currently no specific antiviral treatment or vaccine for severe acute respiratory syndrome coronavirus 
2, and clinical treatment for COVID-19 has so far been limited to prophylaxis and palliative care. Quarantine alone 
is not enough to prevent the spread of COVID-19. Basic health measurements to prevent the spread of the disease 
include frequent handwashing and the use of personal protective equipment such as masks.
CONCLUSION: Extensive research can be the key to solve the existing challenges in the prevention, control, diagnosis, 
and treatment of the disease. The best ways to fight the new corona disease include educating the people, providing 
accurate information, providing personal protective equipment, canceling meetings and emphasizing citizens homeliving 
and regular handwashing, observing social distancing, and finally identifying suspicious cases and quarantine.
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Introduction
On January 7, 2020, the pathogen was 
identified as the new coronavirus, now novel 
coronavirus (nCOV)-2019, or coronavirus disease 
(COVID-19), which is a virus distinguished from 
both severe acute respiratory syndrome coronavirus 
(SARS-CoV) and Middle East Respiratory Syndrome 
coronavirus (MERS-CoV) is distinct [1], [2]. With the 
spread of this endemic disease in China, other cases of 
it were observed outside of China [3]. On January 30, 
2020, the World Health Organization (WHO) declared 
it a public health emergency a International public 
health emergency in the world [4]. As of July 22, 2020, 
14,765,256 people have been infected worldwide and 
612,054 people have died of the virus. Furthermore, in 
Iran, according to the WHO report, as of July 22, 2020, 
278,827 people were infected and 14,634 people died 
due to the virus [5].
According to current epidemiological research, 
the incubation period of the disease is 1–14 days 
(mostly 3–7 days) [6]. The virus is transmitted mainly 
through respiratory droplets and close contact and is 
observed in human respiratory epithelial cells for about 
96 h, first invading the lungs and causing serous fluid, 
fibrin exudate, and the formation of a hyaline membrane 
in the alveoli. Becomes [7], which causes respiratory 
symptoms such as dry cough, dyspnea, fever and 
eventually pneumonia, acute respiratory failure, acute 
respiratory distress syndrome, and other multiple 
organ failures [8], [9]. Furthermore, many patients 
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with COVID-19 have gastrointestinal symptoms such 
as anorexia, abdominal pain, nausea and vomiting, 
and diarrhea even before the onset of respiratory 
symptoms [10]. A study found that about 40% of 
cases suspected of having COVID-19 had symptoms. 
Anorexia, 10% had diarrhea, 8% had non-specific 
abdominal pain, and 8% had nausea and vomiting [11].
The highest mortality and morbidity occurred in 
the elderly and those with underlying disease. Children 
and infants are also vulnerable to this disease [12], [13]. 
According to the National Health Commission of China, 
the death rate in cases confirmed in China was 2.2% 
as of February 4 [14], and among hospitalized patients, 
the mortality rate was between 11% and 15% [6] [15]. 
To increase the safety of patients and to prevent cross-
infection in respiratory infectious patients (such as 
influenza, COVID-19) can be used contact precautions, 
air precautions, and droplet precautions [16]. However, 
treatments supportive drugs are mainly used because 
there is currently no specific effective treatment [17] and 
currently the main focus is on the development of new 
drugs, including antivirals and vaccines [18]. Most people 
infected with or without mild symptoms can spread the 
virus and transmit it to others, which is very challenging 
to prevent the spread of COVID-19. Therefore, strict 
monitoring is very important to prevent sustainable 
transmission [19]. In the first period, the new coronavirus, 
many studies were published on the epidemiology, causes, 
manifestations, and clinical diagnosis and prevention 
and control of the virus. However, studies examining 
prevention and control measures have gradually 
increased. To minimize the impact of prevalence, it is 
necessary to study in this field [20]. 
Countries such as Taiwan and Vietnam have 
been able to control Corona by doing some strict 
hygiene measures, including invasive tests, quarantine, 
tracking contacts with polluted environment, and border 
monitoring. Likewise, Korea could decrease epidemy 
by applying invasive tests, quarantine, accompanied by 
physical distant measures. On the other hand, China 
could control the epidemy using some strategies such 
as compulsory quarantine and invasive tests [21]. 
Moreover, the hygiene system, as well as the community 
of Iran, has been greatly affected by this epidemy 
disease [22]. Regarding the severity of the disease, the 
hygiene system provides some plans to deal with the 
disease. However, because of the extensive dimensions 
of the disease, there would have been so much pressure 
on the hygiene care systems so much that it might not 
be able to compensate its loss regarding its different 
dimensions. These dimensions include financial 
problems, social tension, and hygiene system not 
responding to the patients. Therefore, cooperation and 
collaboration of the society with the health system would 
be influential in control and preventing the disease [23].
Since coronavirus 19 is the third most 
dangerous pandemic virus emerged in the 21st century 
and is one of the most prevalent diseases [19], [20] with 
high mortality and morbidity rate during the disease 
pandemic which has developed worldwide, although 
the effective vaccine to prevent it has not yet been 
made. In the current situation, the only logical way to 
control the disease and reduce its effects and mortality 
rate is to use ways to prevent the disease. Hence, the 
present study was conducted aiming at reviewing the 
epidemiology, prevention and control strategies relevant 
to coronavirus 19. Moreover, no similar systematic 
review study has not been conducted in Iran, this study 
has been done to review the epidemiology, preventive, 
and COVID 19 controlling strategies systematically.
Methods
The aim of this study was to review and classify 
the findings of Latin and Persian articles relevant to 
COVID-19 disease, epidemiology, symptoms, ways of 
control and prevention, as well as existing challenges 
by reviewing articles published by foreign and Iranian 
authors in international and local journals about COVID 
disease-19. In the present review study, articles 
indexed in Persian and Latin databases of SID Magiran, 
PubMed, Scopus, Scholar, Web of Science, Embase, 
MedRxiv, and WHO were examined. The search terms 
regarding the research topic, based on MESH and 
syntax, were: COVID-19, coronavirus, deltacoronavirus, 
SARS-CoV-2, MERS-CoV, SARS virus, prevention, and 
prevalence, prevention and control strategies. In total, 
throughout the present study, on the basis of the above-
mentioned keywords, initially 525 articles, reports, 
and protocols of reputable health organizations were 
studied, as well as the entry and extract criteria of the 
articles were scrutinized. After studying the titles and 
abstracts of articles by the authors of the article and 
excluding the similar and unrelated items, the relevant 
items were selected as research items and 38 studies 
and 5 protocols and reports were reviewed based on 
the abstract and full text of the articles (Figure 1). Due 
to the widespread and increasing prevalence of the 
disease and the changes in the statistics related to the 
prevalence, the statistics presented in this study are 
until July 23, 2020. Criteria for selecting articles are:
1. Descriptive, analytical, interventional, and review 
articles published in the past 5 years.
2. Persian and English articles published in scientific 
research journals in and out of the country, the 
full texts of which were available.
3. Articles related to epidemiological studies, control 
strategies, and prevention of coronavirus 19.
Criteria for excluding articles were: Articles that 
did not have the full text, articles that did not have clear 
implementation methods, and articles that focused only 
on treating the disease rather than ways to prevent and 
control the disease.
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To investigate and analyze the papers elicited 
from searching databases, which were assessed 
and qualified according to input and output criteria 
determined in the methodology, four researchers 
participated in the research. The flowchart for the 
selection of studies was illustrated in Figure 1.
Results
Epidemiology
Throughout history, many infectious diseases 
such as HIV, Ebola, Zika, and H1N1 have been 
emerged [21]. In addition, the Ebola virus outbreak in 
2014 and the Zika virus outbreak in 2015 both caused 
significant damages to countries [21]. The coronavirus 
is an RNA virus weighing 80–120 nm. It is divided into 
four types: Alpha coronavirus, beta coronavirus, gamma 
coronavirus, and delta coronavirus. The recombination 
rate of COV is high due to high transcription errors. 
Despite its high mutation, coronavirus has genetic 
pathogens that occur in humans and animals with a 
wide range of clinical symptoms from the asymptomatic 
period to the need for intensive care, infection of the 
respiratory, gastrointestinal, hepatic, and nervous 
systems [23]. Human coronavirus was neglected long 
before the onset of severe acute coronavirus syndrome 
(SARS-COV) in 2002, and in 2002, in 8096, cases 
with a 10% of mortality rate. Fortunately, public health 
measures, including isolation and quarantine, brought 
SARS to an end in the summer of 2003. After that, the 
Figure 1: Flowchart for selection of studies
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MERS-COV is another coronavirus that has been a 
constant global health threat since 2012. The disease 
was reported in South Korea due to an infected person 
traveling from the Middle East, where in 2015, 186 
cases and 36 deaths were reported. As of November 
2019, MERS-COV has infected 2944 people and killed 
858 [22].
In December 2019, a new beta-coronavirus 
was temporarily renamed coronavirus 2019. It was 
later formally renamed as acute respiratory syndrome 
2 (SARS-COV2) by the International Committee for 
the Classification of Viruses (ICTV). Coronavirus 2019 
(COVID-19) was named SARS-COV-2 [24]. It is the 
seventh type of coronavirus that causes infection in 
humans after SARS-COV and MERS-COV and alike 
them is a beta subset of coronavirus [23]. On January 
30, the WHO declared COVID-19 as an international 
emergency concern. nCOV-2019 is the third most 
dangerous pandemic virus that emerged in the 21st 
century. It is also one of the epidemic diseases [22].
In no time, scientists began researching the 
source of new coronavirus, and the first COVID-19 
genome was extracted on January 10, 2020, by a 
research team led by Professor Zhang Zhang. The new 
virus spread across China within a month of the Chinese 
New Year. As of December 29, 2019, the first four cases 
of acute respiratory syndrome of unknown cause were 
reported in Wuhan, Hubei Province, China, among 
people associated with the local seafood market [20]. 
Most of the sufferers were at the exposure of wild 
animals offered at Wuhan Seafood Wholesale Market. 
Chickens, snakes, bats, and other domestic animals 
were also sold in this market. The scientists’ findings 
showed that bats and minks may be two potential hosts 
for the new coronavirus, while bats were more similar 
to the new coronavirus in terms of infection pattern than 
mink. Thereafter, the China Center for Disease Control 
and Prevention surveyed seafood market products in 
southern China, concluding that the virus came from 
wild animals sold in the market. However, Lost’s report 
on 41 infected patients challenged the finding that “no 
epidemiological link was found between the first patient 
and the next.” The data showed that, in total, 13 of 
the 41 had no connection to the market. Person-to-
person transmission of coronavirus was confirmed by 
Chan et al., who reported that one person infected five 
members of the family [25]. The new coronavirus outbreak 
occurred during the Spring Festival in China, China’s 
most famous traditional festival, with nearly 3 billion 
people attending across China. These conditions have 
brought about proper conditions for the transmission 
of this highly contagious disease and severe problems 
in the prevention and control of the epidemic. The city 
of Wuhan has been the epicenter of the disease with a 
population of about 10 million [24]. From December 31, 
2020, to January 3, 2020, a total of 44 cases of this new 
respiratory disease were reported by Chinese authorities 
to the WHO. As of July 22, 2020, 14,765,256 people 
have been infected worldwide and 612,054 people have 
died of the virus. Furthermore, in Iran, according to the 
WHO report, as of July 22, 2020, 278,827 people were 
infected and 14,634 people died due to the virus [26]. To 
date, the main source of infection has been patients with 
nCOV-2019. Respiratory droplets are the main way of 
transmission and can also be transmitted through close 
contact. Although many details, such as the source of 
the virus and its ability to spread among individuals, are 
yet unknown, an increasing number of cases indicate 
the transmission from human to human [27]. The 
researchers also detected SARS-COV2 in stool, saliva, 
and urine samples. Based on bioinformatics evidence, 
it was shown that the gastrointestinal tract could be a 
potential route for SARS-COV2 infection. In addition, 
SARS-COV2 was observed in the tear and conjunctival 
secretions of COVID-19 patients. Meanwhile, a 
retrospective study of 9 pregnant women with COVID-
19 showed for the 1st time that the possibility of vertical 
intrauterine transmission between mothers and infants 
in late pregnancy was temporarily ruled out. However, 
research is not adequate and more research is needed 
in this regard [23]. The infection is transmitted through 
large droplets sent out by coughing and sneezing by 
symptomatic patients but may also be transmitted by 
asymptomatic individuals. These droplets can spread 
1–2 m and remain on the surface. The virus can survive 
in suitable weather conditions for days but can be killed 
in less than a minute by common disinfectants such 
as sodium hydrochloride and hydrogen peroxide. The 
infection can be transmitted to a healthy person either 
by inhaling these droplets or touching the infected 
surface and then touching the nose, mouth, and eyes. 
Studies show that angiotensin 2 receptor acts as a 
receptor through which the virus enters the respiratory 
mucosa [28] (Table 1).
Symptoms
According to the current epidemiological 
study, the incubation period is generally from 3 days 
to 7 days and a maximum of 14 days. Unlike SARS-
COV, nCOV-2019 is contagious during the commune 
period [27]. However, many different results have 
been reported on the incubation period of this disease. 
Coronavirus SARS-COV2 reproduces efficiently in 
the upper respiratory tract. Infected people produce 
a large amount of the virus in their upper respiratory 
tract during an introductory period, which leads to more 
spread of the virus to other people. Coronavirus SARS-
COV2 also infects cells in the lower respiratory tract 
and multiplies in these organs, causing lesions in the 
lower respiratory tract. Infection with the new SARS-
COV2 new coronavirus is initially associated with 
nonspecific and general symptoms such as nausea, 
fatigue, and body aches, fever, and dry cough. Patients 
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with pre-fever may initially have symptoms of nausea 
and diarrhea. A small number of patients may also 
have headaches or vomiting of blood. It may even be 
asymptomatic. Respiratory failure, septic shock, and 
extrapulmonary organ failure may also occur in severe 
cases [29]. In a study conducted by Chen et al., 51% of 
patients with chronic disease and symptoms such as 
fever (83%), cough (82%), shortness of breath (31%), 
muscle pain (11%), fatigue (9%), headache (8%), sore 
throat (5%), rhinorrhea (4%), chest pain (2%), diarrhea 
(2%), and nausea and vomiting (1%) were reported [15]. 
Patients with cardiovascular disease, chronic disease, 
and people aged 60 and over, and men have a higher 
risk of mortality than the rest of the population. Next 
clinical findings is including: increasing the number of 
white blood cells, mostly neutrophils, with a decrease 
in lymphocytes, platelets and red blood cells. This new 
coronavirus infection causes more severe illnesses 
in the elderly, pregnant women, people with chronic 
debilitating diseases such as diabetes, cardiovascular 
disease, and malignancy [31].
Prevention and Control
Lack of specific clinical features, diagnostic 
microbiological challenge of the new coronavirus 
outbreak, together with seasonal flu, make difficult 
COVID-19 to diagnose. Furthermore, clinical signs such 
as high fever and respiratory symptoms are very similar 
to previous features of coronavirus. There is currently 
no specific antiviral treatment or vaccine for SARS-
COV2, and clinical treatment of COVID-19 has so far 
been limited to prophylaxis and palliative care [22]. In 
the absence of appropriate treatment measurements to 
overcome the virus, the best ways to deal with are to 
prevent the spread of infection and control the sources 
of infection. All sections of society, including employees, 
employers, and workers, must be fully prepared to repel 
the coronavirus, even if the corona epidemic has not 
yet reached that country or region [32]. Prevention of 
this disease, if divided into two levels, individual and 
social, will be as follows:
Individual Prevention
1. Use personal protective equipment such 
as masks [33]; 2. Do washing and disinfecting hands, 
especially after touching surfaces in public places; 
3. Prevent the spread of respiratory droplets when 
coughing or sneezing with a mask and other protective 
equipment; 4. Avoid touching eyes, nose, and mouth; 
5. Avoid attending in crowded places and close contact 
with people; 6. Disinfect the centers that are most 
exposed to touch [34]; 7. Stay at home when you feel 
disease; 8. Abstain from smoking and any action that 
causes damage to the lungs; 9. Follow the government 
guidelines [35]; 10. Do not share your personal items 
such as towels, bedding, either at home or at work [36]; 
11. Wash your personal items with soap and water after 
using [37]; 12. Do not shake hands nor hug others when 
greeting in the workplace or home; 13. Avoid crowded 
public means of transportation and crowded centers 
such as hospitals, clinics, and any other public places; 
14. Avoid physical contact with pets such as touching, 
petting, kissing, or eating together; 15. If animal care is 
necessary, wear a mask and wash your hands before 
and after touching pets; 16. Stay home for 14 days in 
case you are returning from areas with COVID-19 [36]; 
and 17. Wearing a simple surgical mask by patients [33].
Social Prevention
1. Restrictions on travel, especially international 
travel; 2. Screening of people in offices when entering 
and controlling for signs [34]; 3. Observance of the 
social distance of at least 2 m to reduce exposure and 
cut the transmission chain; 4. Cleaning and disinfecting 
infected surfaces and items in cities to eliminate and 
inactivate the virus [38]; 5. Quarantine and movement 
restrictions in infected areas; 6. Early identification 
of infected people; 7. Provide appropriate care for 
patients; 8. Identify and reduce transmission from 
animal resources; 9. Minimize social and economic 
impact through multispectral partnerships [30]; 10. 
School closures [41]; 11. Use of appropriate equipment, 
including N95 masks and protective clothing and 
goggles by health care providers [22]; 12. Preventing 
sick employees from entering the workplace; 13. 
Giving compulsory sick leave to sick or suspected 
employees; 14. Separating and isolating patients 
and suspects from other employees; 15. Establish 
proper ventilation systems in workplaces; 16. Use 
glass or plastic barrier between staff and clients or 
visitors; 17. Use of disposable tools and equipment; 
18. Continuous training the employees regarding the 
observance of hygienic rules, handwashing, and how 
to use protective equipment; 19. Reducing staff working 
hours; 20. Reducing unnecessary missions and trips of 
employees; and 21. Restricting staff gatherings in sports 
and religious centers and holding remote meetings [32].
Quarantine alone is not enough to prevent 
the spread of COVID-19. A lot of countries have done 
controlling measurements, including a combination 
of increasing hygienic acts, travel restrictions, case 
diagnosis, contact tracking, and remote activities. 
Their overall goal is to reduce the number of contacts 
of the population, thus preventing the transmission 
of infection [24]. While many common precautions 
are being taken to stop the spread of SARS-COV2, 
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Title Authors Year Study selection Samples Results Ref.
Unique epidemiological and 
clinical features of the emerging 
2019 novel coronavirus 
pneumonia (COVID-19) implicate 
special control measures
Wang  et al. 2020 Review 92 articles Majority of infected individuals with no or mild symptoms can release 
viruses and spread viruses to others, which is extremely challenging 
for preventing the spread of COVID-19. Active interventions, including 
nutrition supplement, symptomatic treatment, and antiviral treatment 
are critical for mild patients as well as severe patients. Prophylactic 
vaccination is highly demanded for future prevention of emerging 
coronavirus related epidemics or pandemics
[19]
Epidemiology, causes, clinical 
manifestation and diagnosis, 
prevention and control of 
coronavirus disease (COVID-19) 
during the early outbreak period: A 
scoping review
Adhikari  et al. 2020 Review 65 articles This study shows a holistic picture of the current research in response 
to the outbreak of COVID-19. Most studies have focused on the 
epidemiology and potential causes. However, studies exploring prevention 
and control measures have begun to gradually increase. Studies in this 
domain are urgently needed to minimize the impact of the outbreak
[20]
Pandemic fear and COVID-
19: Mental health burden and 
strategies
Ornell  et al. 2020 Review 26 articles It is extremely necessary to implement public mental health policies in 
conjunction with epidemic and pandemic response strategies before, 
during and after the event. Mental health professionals must be on the 
front line and play a leading role in emergency planning and management 
teams
[24]
2019 novel coronavirus (2019-
nCoV) outbreak: A new challenge
Lupia  et al. 2020 Review 225 articles The new 2019-nCoV epidemic is mainly associated with respiratory 
disease and few extrapulmonary signs. However, there is a low rate of 
associated pre-existing respiratory comorbidities
[25]
A review of coronavirus 
disease-2019 (COVID-19)
Singhal 2020 Review 32 articles Prevention entails home isolation of suspected cases and those with mild 
illnesses and strict infection control measures at hospitals that include 
contact and droplet precautions. The virus spreads faster than its two 
ancestors, the SARS-CoV and MERS-CoV, but has lower fatality
[26]
2019 novel coronavirus (COVID-
19) outbreak: A review of the 
current literature
Sahin  et al. 2020 Review 36 articles Coronaviruses will cause spreads and outbreaks with different-
mutant strains similarly in the coming years. With increased scientific 
collaboration, which is a result of globalization, we may have more 
powerful means of fighting against coronaviruses, in which we know the 
genome structure very well in the future
[27]
2019 novel coronavirus: Where 
we are and what we know
Cheng and 
Shan 
2020 Review 32 articles By fitting the number of infections with a single-term exponential model, we 
report that the infection is spreading at an exponential rate, with a doubling 
period of 1.8 days
[28]
A rapid advice guideline for the 
diagnosis and treatment of 2019 
novel coronavirus (2019-nCoV) 
infected pneumonia
Jin  et al. 2020 Review 38 articles This rapid advice guideline is suitable for the first frontline doctors and 
nurses, managers of hospitals and healthcare sections, community 
residents, public health persons, relevant researchers, and all person who 
are interested in the 2019-nCoV
[29]
A review of the 2019 novel 
coronavirus (COVID-19) based on 
current evidence
Wang  et al. 2020 Review 73 articles This review in the hope of helping the public effectively recognize and deal 
with the 2019 novel coronavirus (SARS-CoV-2) and providing a reference 
for future studies
[30]
Novel coronavirus disease 
2019 (COVID-19): An emerging 
infectious disease in the 21st 
century
Tavakoli  et al. 2020 Review 53 articles The outbreak caused by the novel coronavirus is larger than the previous 
human coronaviruses; however, the mortality rate of COVID-19 is lower 
than that of other coronaviruses diseases such as SARS or MERS and 
other viruses. At present, due to the lack of an effective treatment and 
vaccine, the best way to deal with the COVID-19 disease is to prevent 
transmission and spread of the virus and to execute personal protective 
measures
[31]
COVID-19 and substance use 
disorders: Recommendations 
to a comprehensive healthcare 
response
Mokri  et al. 2020 Review 128 articles In this paper, an international group of experts on addiction medicine, 
infectious diseases, and disaster psychiatry explore the possible raised 
concerns in this issue and provide recommendations to manage the 
comorbidity of COVID-19 and substance use disorder (SUD)
[32]
Novel coronavirus 2019-nCoV: 
Prevalence, biological, and clinical 
characteristics comparison with 
SARS-CoV and MERS-CoV
Meo  et al. 2020 Review 18 articles The 2019-nCoV has epidemiological and biological characteristics, making 
it more contagious than SARS-CoV and MERS-CoV. Although the fatality 
rate of MERS-CoV was higher than them. The major clinical manifestations 
in coronavirus infections 2019-nCoV are fever, chills, cough, shortness 
of breath, generalized myalgia, malaise, drowsy, diarrhea, confusion, 
dyspnea, and pneumonia. Global health authorities should take immediate 
measures to prevent the outbreaks of such emerging and reemerging 
pathogens across the globe to minimize the disease burden locally and 
globally
[33]
Approaches for COVID-19 
infection control in the workplace. 
Occupational Medicine. 2019
Rafeemanesh  
et al.
2019 Review 19 articles All members of the society, including employers, employees and laborers, 
should be completely ready to overcome the virus, even if the epidemic 
has not been spreading in that country or area. This point can be effective 
on the reduction of lost workdays, work absenteeism, and prevent the 
spread of the virus in the community
[34]
Review on the symptoms, 
transmission, therapeutics options 
and control the spread of the 
disease of COVID-19
Irani 2020 Review 22 articles The extensive functions have been carried out to reduce person-to-person 
transmission of COVID-19. In this review, the symptoms, epidemiology, 
transmission, pathogenesis, phylogenetic analysis, and future directions to 
control the spread of this fatal disease have been presented
[35]
A review of the new 21st 
century coronavirus (novel 
coronavirus-2019)
Ghaderi  et al. 2020 Review 47 articles Accordingly, it is considered a serious global threat and all necessary 
precautions should be taken in the event of any suspected case. 
Experiences from (MERS) and (SARS) highlight the importance of rapidly 
finding the source for 2019-nCoV to stem the ongoing outbreak
[36]
Coronavirus: Origins, signs, 
prevention, and management of 
patients
Hill 2020 Review 17 articles It is important that, in these difficult times, nurses understand the 
symptoms of COVID-19, how to prevent its spread, and are up-to-date on 
the guidance on critical care
[37]
Coronavirus disease (COVID-19) 
outbreak and the strategy for 
Prevention
Sajed and 
Amgain
2020 Review 6 articles Eradication of highly contagious SARS-CoV-2 virus that causing the 
ongoing deadly pandemic COVID-19 demands individual attention and 
awareness is necessary regarding the route and mode of transmission 
across the bounders throughout entire world. Proper handwashing, staying 
in-home, and maintaining the social distance are proved to be the most 
effective preventive measures which are immediate solution to save 
human being from this unseen enemy
[38]
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other less common transmission pathways should be 
considered and taken to reduce the spread [42]. The 
effectiveness of school closures is limited, although a 
2-week delay in the peak of the epidemic does not have 
a significant effect on the peak size of the disease [41]. 
The greatest risk of COVID-19 is transmission to health 
care workers. At the outbreak of SARS in 2002, 21% 
of these people were affected by health care workers. 
Protecting the transmission of infection to other patients 
is important. Patients should be placed in separate 
rooms or next to each other. Negative pressure in 
rooms is generally not required [22].
Discussion
Research studies which assess the rate of 
COVID-19 interventions are limited and even if they are 
available, they either consider just one intervention, or 
they had been done in other fields of study. Therefore, 
the present study would be influential in dealing with 
disease by providing some major perspectives elicited 
from the collection of papers through investigating 
controlling, as well as personal and social preventive 
strategies. 
Numerous features of the virus make it 
difficult to prevent, including non-specific features 
of the disease, infection even before the onset of 
symptoms during the incubation period, transmission 
from asymptomatic individuals, long incubation period, 
prolongation of the disease, and transmission even 
after its clinical improvement [26].
There is no single intervention to adequately 
control or reduce the epidemic of the disease. A 
combination of several influential measures such as 
keeping the social distance, doing several diagnostic 
tests, and identifying positive cases would probably 
decrease the burden of the epidemic. However, it is 
essential to start synergic treatment earlier and continue 
appropriately. If following social distance and strict 
measures to diagnose the cases and tracking them 
start earlier but stops in <6 months, the disease burden 
and mortality rate would increase again, growing the 
demand for receiving hygienic care. While in doing 
early, invasive and long interventions, it would be easier 
to control the disease for a longer time. It seems that 
diagnosing marked patients, separating, intervening 
proceeding is the footstone of each successful 
controlling strategy [23].
Regarding recent findings, almost half of disease 
transmissions maybe before the symptom occurrence 
phase [43]. Therefore, keeping the social distant and 
keeping schools off to reduce personal contacts are logical 
and important ways. While dealing with an uncontrollable 
disease, hygienic systems of the countries with limited 
sources are significantly under pressure; thus, the 
morbidity and mortality rate would be 2 times of expected 
amount. If an uncontrollable disease is updating itself, 
even adding the number of hospital beds significantly 
does not work to decrease the mortality rate [23].
Several challenges have been posed by the 
COVID-19 epidemic, one of which is that the true extent 
of COVID-19 and the scale of its possible prevalence 
are not known precisely, and the actual number of 
infected and suspected patients is not identifiable [44].
Extension of corona resulted in a decrease 
of enormous economic and social offices all over the 
world. To decrease the financial loss resulted from 
the disease, as well as to support the small, stricken 
careers, most countries consider protective acts such 
as grants and tax reductions [45]. The propose theory 
is that it is possible that people are tired of following 
the long intervention; moreover, doing social distance 
can result in unwanted hygienic, economic, and welfare 
consequences, the subject that would probably affect 
strongly on a lot of countries who do not care on 
following the social security principles [46], [47].
 The mortality and transmission rate of patients 
with COVID-19 vary in different findings [48]. On 
the other hand, more studies should be done on the 
following: How the virus is easily transmitted among 
people? How can it affect vulnerable subgroups such as 
the elderly or people with chronic diseases? What is the 
source of the virus? And how can it spread worldwide 
in such a short period of time [49]. Another challenge 
is whether nCOV-2019 disease is transmitted directly 
from bats or through an intermediate host. Wang et 
al. stated that one of the challenges is that “time is so 
Title Authors Year Study selection Samples Results Ref.
Modeling transmission and control 
of the COVID-19 pandemic in 
Australia
Chang  et al. 2020 Review 58 articles School closures are not found to bring decisive benefits unless coupled with 
high level of social distancing compliance. We report an important transition 
across the levels of social distancing compliance, in the range between 
70% and 80% levels. This suggests that compliance of below 70% is 
unlikely to succeed for any duration of social distancing, while compliance 
at the 90% level is likely to control the disease within 13–14 weeks when 
coupled with effective case isolation and international travel restrictions
[39]
2019 novel coronavirus (COVID-
19) pandemic: Built environment 
considerations to reduce 
transmission
Dietz  et al. 2020 Review 96 articles We hope this information can help to inform the decisions and infection 
control mechanisms that are implemented by corporate entities, federal, 
state, county, and city governments, universities, school districts, places 
of worship, prisons, health care facilities, assisted living organizations, 
daycares, homeowners, and other building owners and occupants to 
reduce the potential for transmission through BE-mediated pathways
[40]
Table 1: (Continued)
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limited that we cannot fully account for all the clinical 
problems with this emergency; second, much of the 
evidence from data retrieval is indirect” [5]. One of the 
existing problems is social media. In addition to sharing 
content quickly, social media also quickly spreads 
rumors, misunderstandings, and intimidation [20]. 
Only extensive research can be the key to solving the 
existing challenges and we hope that future studies will 
focus on the development of COVID-19 vaccines and 
effective drugs to treat them to reduce mortality.
Conclusion
According to studies and reports, the best way 
to overcome new corona disease is to prevent new 
cases and control the disease. Given the unknown 
characteristics of COVID-19, it is recommended that all 
organizations work to prevent and control the disease 
and break the transmission chain. To achieve this goal, 
the best solution is to educate the community, provide 
accurate information, provide sufficient personal 
protective equipment, allocate funds to fight the disease, 
abolish all communities, and emphasize on citizens 
staying home and washing their hands regularly, 
observe social distance, providing adequate diagnostic 
and treatment facilities, establishing fever measuring 
rooms in all stations, airports and public places, and 
finally identify suspected cases and quarantining.
The uncontrollable epidemic of COVID-19 
has the potential to lead to a huge amount of death, 
strengthening with unanswered demand to hygienic 
measures. Results indicate that the best strategy is to 
control facing epidemic is a combination of interventions 
aiming at diagnose, reducing the contact, through some 
physical actions, and doing quarantine for infected people. 
Restricting the measures would prevent the extension of 
the epidemic, but if additional control measures would not 
be implemented, it would probably low in value.
It is essential that all managers, employers, 
and business owners be provided with the necessary 
information and training on prevention and control of 
COVID 19 disease based on health guidelines and 
protocols to reduce the number of patients and prevent 
the spread of the disease in society. 
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